Beneficial effect of fluoxetine in a case of sporadic hyperekplexia

Clinical Neuropharmacology

Volumn 23, Issue 3, 2000, Pages 161-163

  Sechi, Gianpietro ^a,c   Sotgiu, Stefano ^a   Valenti, Maria P ^a   Pitzolu, Maria G ^a   Peterlongo, Paolo ^b   Larizza, Lidia ^b   Rosati, Giulio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Neurological Clinic   (Italy)

Author keywords

Fluoxetine; Hyperekplexia; Serotonergic mechanisms

Indexed keywords

FLUOXETINE;

AGED; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STARTLE EPILEPSY; STARTLE REFLEX; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; FLUOXETINE; HUMANS; MENTAL DISORDERS; SEROTONIN; STARTLE REACTION;

EID: 0034130236     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200005000-00006     Document Type: Article

References (13)

1. 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 1993; 5:351-8.
2. Green JP. Histamine and serotonin. In: Siegel G, Agranoff B, Albers RW, Molinoff P, eds. Basic Neurochemistry, Fourth Edition. New York: Raven Press, 1989:253-69.
3. Andermann F, Keene DL, Andermann E, Quesney LF. Startle disease or hyperekplexia: further delineation of the syndrome. Brain 1980;103:985-97.
4. Saenz-Lope E, Herranz FJ, Masdeu JC. Startle epilepsy: a clinical study. Ann Neurol 1984;16:78-81.
5. Elmslie FV, Mulchings SM, Spencer V, et al. Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis. J Med Genet 1996;33:435-6.
6. White WF, Heller AH. Glycine receptor alteration in the mutant mouse spastic. Nature 1982;298:655-7.
7. Kingsmore SF, Giros B, Suh D, Bieniarz M, Caron MG, Seldin MF. Glycine receptor b-subunit gene mutation in spastic mouse associated with line-1 element insertion. Nat Genet 1994;7:136-42.
8. Andrew M, Owen MJ. Hyperekplexia: abnormal startle response due to glycine receptor mutations. Br J Psychiatry 1997;170:106-8.
9. Tijssen MA, Shoemaker HC, Edelbroek PJ, Roos RA, Cohen AF, Van Dijk JG. The effects of clonazepam and vigabatrin in hyperekplexia. J Neurol Sci 1997;149:63-7.
10. Saenz-Lope E, Herranz-Tanarro FJ, Masdeu JC, Chacon Pena JR. Hyperekplexia: a syndrome of pathological startle responses. Ann Neurol 1984;15:36-41.
11. Stark P, Fuller RW, Wong DT. The pharmacologic profile of fluoxetine. J Clin Psychiatry 1985;46:7-13.
12. Brotman AW, Falk WE, Gelenberg AJ. Pharmacologic treatment of acute depressive subtypes. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press, 1987:1031-40.
13. Matsumoto J, Fuhr P, Nigro M, Hallet M. Physiological abnormalities in hereditary hyperekplexia. Ann Neurol 1992;32:41-50.